Recently a dapF mutant of Escherichia coli lacking the diaminopimelate epimerase was found to have an unusual large LL-diaminopimelic acid (LL-DAP) pool as compared with that of meso-DAP (C. Richaud, W. Higgins, D. Mengin-Lecreulx, and P. Stragier, J. Bacteriol. 169:1454-1459. In this report, the consequences of high cellular LL-DAP/meso-DAP ratios on the structure and metabolism of peptidoglycan were investigated. For this purpose new efficient high-pressure liquid chromatography techniques for the separation of the DAP isomers were developed. Sacculi from dapF mutants contained a high proportion of LL-DAP that varied greatly with growth conditions. The same was observed with the two DAP-containing precursors, UDP-N-acetylmuramyl-tripeptide and UDP-N-acetylmuramyl-pentapeptide. The limiting steps for the incorporation of LL-DAP into peptidoglycan were found to be its addition to UDP-N-acetylmuramyl-L-alanyl-Dglutamate and the formation of the D-alanyl-DAP cross-bridges. The Km value of the DAP-adding enzyme for LL-DAP was 3.6 x 10-2 M as compared with 1.1 x 10-5 M for meso-DAP. When isolated sacculi were treated with Chalaropsis N-acetylmuramidase and the resulting soluble products were analyzed by high-pressure liquid chromatography, the proportion of the main peptidoglycan dimer was lower in the dapF mutant than in the parental strain. Moreover, the proportion of LL-DAP was higher in the main monomer than in the main dimer, where it was almost exclusively located in the donor unit. There are thus very few D-alanyl-LL-DAP cross-bridges, if any. We also observed that large amounts of LL-DAP and N-succinyl-LL-DAP were excreted in the growth medium by the dapF mutant.
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In Escherichia coli free diaminopimelic acid (DAP) is present both in the LL and meso forms at approximately equal pool levels (21) . LL-DAP is the immediate precursor of meso-DAP, which is either decarboxylated to yield L-lysine (25) or used in peptidoglycan biosynthesis by its addition to UDP-N-acetylmuramyl-L-alanyl-D-glutamate (UDP-Mur NAc-L-Ala-D-Glu) to yield UDP-MurNAc-L-Ala-y-D-Glumeso-DAP (28) . The interconversion of the LL and meso isomers of DAP is catalyzed by an epimerase, detected 30 years ago (2) and only recently purified and studied in detail (35) . This enzyme has been considered as a possible target for antibacterial effects (14) .
Recently, the dapF gene coding for this epimerase was cloned, and insertional mutagenesis was performed on it (27) . A dapF mutant was obtained by transferring one of the insertions onto the chromosome by a double-recombination event. This mutant accumulated large amounts of LL-DAP, confirming a block in the step catalyzed by the dapF product, but did not require meso-DAP for growth. Moreover, a meso-DAP pool was still detectable, a result which correlated well with the Dap+ phenotype. It was speculated that there might be in E. coli another enzyme capable of catalyzing the conversion of LL-DAP to meso-DAP at a rate sufficient to sustain growth.
In the present report, the consequences of the high LL-DAP/meso-DAP ratios in cells encountered in dapF mutants on peptidoglycan metabolism and structure were investigated. Analysis of a possible incorporation of LL-DAP into peptidoglycan and its precursors was studied. For this MATERIALS AND METHODS Bacterial strains, media, and growth conditions. The E. coli strains used in this study are listed in Table 1 . Cells were grown as previously described (22) in Penassay broth (AM3; Difco Laboratories, Detroit, Mich.), LB medium, or minimal medium M63 supplemented with glucose (0.2%), thiamine (0.5 mg liter-'), and the required amino acids (100 ,ug ml-').
In all cases, 2-liter flasks containing 500 ml of medium were inoculated with 0.5 ml of overnight precultures, and growth was monitored by measuring the optical density at 600 nm in a Gilford model 240 spectrophotometer.
Chemicals and analytical procedures. The three isomers (DD, LL, and meso) of DAP, UDP-MurNAc-L-Ala-D-Glu, and UDP-MurNAc-L-Ala-y-D-Glu-meso-DAP were secured by previously described methods (11, 30) . Chalaropsis Nacetylmuramidase was kindly provided by G. Seibert (Hoechst, Frankfurt, Federal Republic of Germany). All reagents were of commercial analytical grade. Marfey reagent (20) , 1-fluoro-2,4-dinitrophenyl-5-L-alanine amide, was bought from Pierce Chemical Co. (Rockford, Ill.). DL- [14C]glutamic acid was purchased from CEA (Saclay, France) . N-Succinyl-LL-DAP was kindly provided by F. Blanche (Rhone-Poulenc, Vitry, France). HPLC and fastprotein liquid chromatography were carried out as previously described (1, 11, 23 This studya a This strain was constructed by P1 transduction in the same way as other dapF::Mu dII PR13 strains described previously (27) .
95°C for 16 h and by using o-phthalaldehyde and 2-mercaptoethanol as reagents. Determination of DAP pool levels and isolation of the two DAP-containing nucleotide precursors. Cultures (1 liter) of midexponential-phase cells (200 mg of bacterial dry weight per liter of culture) were rapidly chilled to 0°C, and cells were harvested in the cold. Extracts were prepared as previously described (21) , and their total DAP (LL and meso isomers) content was estimated directly with the amino acid analyzer without prior hydrolysis. From such extracts the two DAP-containing precursors UDP-MurNAc-tripeptide and UDP-MurNAc-pentapeptide were isolated and purified (21) .
Isolation of sacculi and quantification of peptidoglycan. Cells from 1-liter cultures were rapidly chilled to 0°C and harvested in the cold. Pellets were washed with a cold aqueous 0.85% NaCl solution and centrifuged again. Bacteria were then rapidly suspended under vigorous stirring in 40 ml of a hot (95 to 100°C) aqueous 4% sodium dodecyl sulfate solution for 30 min. After standing overnight at room temperature, the suspensions were centrifuged for 90 min at 100,000 x g, and the pellets were washed several times with water. Final suspensions made in 5 ml of water were homogenized by brief sonications. The peptidoglycan content of sacculi was expressed in terms of their DAP content.
Separation of LL-and meso-DAP. The relative amounts of LL-and meso-DAP in cell extracts or in hydrolysates from peptidoglycan or peptidoglycan fragments and precursors were determined by the HPLC technique that we recently developed (27) . Bis-4-dimethylaminoazobenzene-4'-sulfonyl (dabsyl) derivatives of these DAP isomers were made by the method of Chang et al. (6) and then separated and quantified on a LiChrosorb RP-18 column (4.0 by 250 mm; E. Merck AG, Darmstadt, Federal Republic of Germany). Operating conditions were either an isocratic elution at 37°C with 12 mM ammonium phosphate (pH 6.5)-acetonitrile-dimethylformamide (69:27:4, vol/vol/vol) at a flow rate of 1 ml min-' or a gradient elution at 37°C with 12 mM ammonium phosphate (pH 6.5) containing dimethylformamide (4%) and 12 to 60% acetonitrile (Fig. 1) . The second procedure was preferred when quantification of amino acids other than the DAP isomers was required. In all cases, detection was performed at 436 nm (Beckman 160 absorbance detector) and at a sensitivity of 0.01 absorbance unit, full scale. Results were quantified with a Delsi icap 10 integrator (Delsi, Suresnes, France). This method did not allow for the separation of the DD and LL isomers of DAP. Before dabsylation DAP was quantitatively recovered from cell extracts or peptidoglycan hydrolysates with the amino acid analyzer run without the o-phthalaldehyde reagent. This purification step was unnecessary when considering hydrolysates of peptidoglycan fragments or precursors purified by HPLC.
HPLC analysis of peptidoglycan. The structural analysis of Glauner and Schwarz (15; B. Glauner, Anal. Biochem., in press) slightly modified. Peptidoglycan of crude isolated sacculi was in all cases digested to an extent of 92 to 94% by Chalaropsis N-acetylmuramidase. The resulting soluble fragments were reduced by sodium borohydride. The separation of the reduced compounds was achieved by reversephase chromatography with a LiChrosorb RP-18 column (4 by 250 mm) and a gradient elution with a sodium phosphate buffer and methanol as the organic modifier. Products were identified either by comparison with compounds of known structure (31, 32) or by reference to the retention times given by Glauner (in press). Owing to the specificity of the muramidase used, the degradation of E. coli peptidoglycan led to many fragments which were all essentially monomers, dimers, trimers, and tetramers of the disaccharide N-acetylglucosaminyl-,-1-4-N-acetylmuramic acid or of the disaccharide N-acetylglucosaminyl-p-1-4-1,6-anhydro-N-acetylmuramic acid.
In the present work we considered only the two main degradation products, which were the disaccharide tetrapeptide monomer and its dimer and which together account for ca. 60% of the degraded peptidoglycan material (15) . They were originally designated as compounds C6 and C3 (32) and more recently as tetra and tetra-tetra (Glauner, in press ). These latter designations were used in this report as well as the designation penta for the disaccharide pentapeptide and tetra-penta for the corresponding dimer. The respective amounts of monomer tetra and dimer tetra-tetra were determined by quantitation of their DAP content after their isolation by HPLC. These values were in agreement with those obtained by directly determining the area of the corresponding peaks recorded during HPLC. This amounts to saying that the molar extinction coefficient of dimer tetra-tetra is double that of that of monomer tetra.
Enzyme assays and determination of Km values. Partially purified DAP-adding and D-alanyl-D-alanine-adding enzymes were prepared from E. coli K-12 HfrH as previously described (1, 23 ). An additional purification step on a Q Sepharose Fast Flow column (Pharmacia, Uppsala, Sweden) connected to a fast-protein liquid chromatography apparatus was necessary to remove DAP epimerase activity from the DAP-adding enzyme. The activities of the DAP-adding and D-alanyl-D-alanine-adding enzymes were both tested as previously described (1, 23) . The Km values for LL-DAP, meso-DAP, UDP-MurNAc-L-Ala-y-D-Glu-meso-DAP, and UDP-MurNAc-L-Ala-y-D-Glu-LL-DAP were determined by the method of Wilkinson (33) . Graphic representations of the results are shown in Fig. 2 .
was added to UDP-MurNAc-L-Ala in a reaction catalyzed by the D-Glu-adding enzyme that was partially purified from E. coli as previously described (23 The formation of UDP-MurNAc-tripeptide was followed by HPLC analysis at different times during incubation. UDPMurNAc-tripeptide was isolated from the reaction mixture by gel filtration on Sephadex G25 (21) . Further purification was performed by HPLC on a puBondapak C18 column (7.8 by 300 mm) eluted with 0.05 M ammonium formate, pH 4 (11) . Owing to a poor separation from ATP, a second HPLC was performed under the same conditions, but at pH 4.65, to insure a proper purification. The LL-DAP/meso-DAP ratio of the final product was 88:12.
RESULTS Effects of the absence of the dapF gene product. With the three growth media considered, the JC7623 dapF strain had longer generation times than parental strain JC7623 (Table  2 ). Furthermore, it had been shown (27) that the dapF mutant had a very high free LL-DAP pool, at least when cells were grown in minimum or LB medium. The much lower LL-DAP pool observed with cells grown in Penassay medium (Table 2) was presumably due to a repression of the DAP pathway by the lysine from the medium (25) . With the HPLC technique developed to analyze LL-and meso-DAP mixtures we were able to ascertain the presence of a pool of free meso-DAP as well. But owing to the high LL-DAP pool its accurate quantification was a difficult matter, and no additional specific technique was developed for this purpose. The meso isomer accounted for ca. 0.1 to 1% of the LL isomer. Furthermore, it could not a priori be excluded that some DD isomer was also present, since it had the same retention time as the LL isomer with the technique used. To verify the absence of any DD isomer in the pools analyzed, an HPLC technique with Marfey chiral reagent (20) was developed to separate all three DAP isomers (Fig. 3) . Under these conditions no DD-DAP was detected in the cell pool of a dapF mutant.
LL-DAP in the peptidoglycan of the dapF mutant. Sacculi were isolated from strain JC7623 dapF and from parental strain JC7623. For a given growth medium, similar amounts of peptidoglycan were recovered. Furthermore, they all contained equimolar amounts of muramic acid, DAP, and glucosamine. However, when the LL-and meso-DAP contents were analyzed by HPLC, important differences were observed (Table 3) . Sacculi from the parental strain contained essentially meso-DAP. Less than 1% of DD and LL isomers was detectable. Presumably this trace amount of these isomers resulted from a slight epimerization of the meso isomer during hydrolysis and did not originate from intact peptidoglycan itself. This was substantiated by the fact that DAP from the peptidoglycan of a dapF strain contained ca. 0.5% of the DD isomer, whereas none was detectable in the cell pool (Fig. 3) . With other techniques trace amounts of LL-and DD-DAP have been detected in the hydrolysis products of E. coli peptidoglycan (8) . Sacculi from the dapF mutant strains contained a high proportion of LL-DAP which varied greatly with growth conditions (Table   3 Indeed, when isolated from strain JC7623 dapF, these two precursors were found to contain LL-DAP (Table 3) . Moreover, the value of the LL-DAP/meso-DAP ratio paralleled that of the corresponding peptidoglycan for the various growth conditions considered. This ratio was low for precursors from cells grown in minimum medium, slightly higher for the LB medium, and much higher for the Penassay medium. This increase was observed with both precursors. However, the ratio was higher in UDP-MurNAc-pentapeptide than in UDP-MurNAc-tripeptide. Furthermore, the LL-DAP/meso-DAP ratio was approximately the same in peptidoglycan as in UDP-MurNAc-pentapeptide, regardless of the growth medium.
In vitro formation of the LL-DAP-containing precursors. The addition of DAP to the UDP-MurNAc-L-Ala-D-Glu precursor is catalyzed in E. coli by a specific ligase coded by the murE gene and recently partially purified (1). This activity appeared fairly specific for meso-DAP, since neither L-lysine, LL-DAP, nor DD-DAP had an inhibitory effect at l0' M (1, 21) . However, the addition of LL-DAP was observed when it was incubated with the partially purified murE gene product at concentrations ranging from 4 x 10-3 to 5 x 10-2 M. Since radioactive LL-DAP was not readily available, UDP-MurNAc-L-Ala-D-[14C]Glu was specially prepared for this assay. The Km value estimated for LL-DAP was 3.6 x 10-2 M (Fig. 2B) and should be compared with the value of 1.1 x 10' M determined for the meso-isomer ( Fig.   2A) .
To examine the effect of the presence of a LL-DAP residue at the C-terminal end of the UDP-MurNAc-tripeptide precursor on the subsequent addition of D-alanyl-D-alanine, a certain amount of LL-DAP-containing precursor was prepared in vitro with partially purified DAP-adding enzyme essentially devoid of epimerase activity. When this nucleotide precursor was tested as a substrate in the assay for D-Ala-D-Ala-adding activity by using a partially purified murF gene product (23) , formation of UDP-MurNAc-pentapeptide was observed. However, the UDP-MurNAc-tripeptide used still contained 12% meso-DAP. One explanation for this might be the presence of minute amounts of meso-DAP in the synthetic LL-DAP used for the preparation of the precursor: the much more favorable Km for meso-DAP would have led to an initial preferential consumption of the residual meso-DAP. Another possibility might be that the DAP-adding enzyme preparation used still contained traces of epimerase. The difficulty of determining the exact Km value for the LL-DAP-containing precursor was overcome by using the equation developed (2) which is analogous to the Michaelis-Menten equation and can be processed by Wilkinson's method or linearized by conventional procedures (Fig. 2D) . Let A and B be the UDP-MurNAc-L-Ala--y-D-Glu-LL-DAP and the UDP-Mur NAc-L-Ala--y-D-Glu-meso-DAP, respectively. Taking into account that x = 12/88 = 0.14, processing of equation 2 by the method of Wilkinson gave KaKJ(Kb + xKa) = 3.6 x 10' M. Since Kb (the Km for UDP-MurNAc-L-Ala--y-D-Glumeso-DAP) was determined to be 1.9 x 10' M (Fig. 2C), we deduced that Ka (the K,, for UDP-MurNAc-L-Ala-y-DGlu-LL-DAP) was 4.9 x 10 M. (16, 31, 32) . Recently, an HPLC technique enabling the easy analysis of such complex mixtures was developed (15; Glauner, in press). When the peptidoglycan of sacculi isolated from strains JC7623 and JC7623 dapF were analyzed in this way, notable differences were observed (Fig. 4) . The mnost con'spicuous concerned the mnaini monomer and dimer. By quantitationi of these two fragments after their HPLC separation the degree of cross-linkage was evaluated in each case (Table 4) . Whatever the growth mediu'm, there was less dimer in the dapF mutant than in the parental strain, but the difference was small in minimal medium-grown cells, high'er in LB medium, and far higher ini Penassay medium. This decrease in dimer correlated with the increase of the LL-DAP/meso-DAP ratio of peptidoglycan. This indicated that the presence of LL-DAP was perhaps a hindrance for the formation of dimers. Another difference concerned variations in the tripeptide monomer content. It decreased notably in the dapF mutant grown in LB or Penassay medium (Fig. 4) . Although no analysis of the minor constituents of the digested peptidoglycan material was undertaken, clearly other differences were noticeable; for instance, minor dimers and trimers were in much lower amounts in peptidoglycan from dapF cells grown in Penassay medium.
LL-DAP/meso-DAP ratio in the main mononier and dimer. Since the decrease in dimer content apparently paralleled the increase in LL content in the peptidoglycan of the dapF mutant, the main monomer and dimer were recovered in each case, and their LL-DAP/meso-DAP ratio was determined (Table 3) . Clearly more LL-DAP was present in the monomer than in the dimer whatever the growth medium. Furthermore, the LL-DAP content was higher than the meso-DAP content in the monomer from cells grown in rich media. Considering the relative amounts of monomer and dimer and their LL-DAP/meso-DAP ratio, an average distribution of both isomers was calculated. In each case the values correlated well with the LL-DAP/meso-DAP ratio determined for whole peptidoglycan. This agreement stressed the validity of the analytical methods used and the fact that the main monomer and dimer by themselves reflected the isomer distribution of the entire peptidoglycan although they accounted for only part of it.
These results further prompted us to determine in the dimer the distribution of LL-and meso-DAP between the donor and acceptor units. The dimer isolated by HPLC was dinitrophenylated, and the LL-DAP/meso-DAP ratio of the nondinitrophenylated DAP residue of the acceptor unit was determined. A value of ca. 0.02 to 0.03 was estimated for this ratio (Table 3) . LL-DAP was thus almost exclusively in the donor unit of the dimer, that is, the unit which has a DAP residue with a free amino group not engaged in the crosslinkage (Table 3) . Since the LL-DAP content of the dimer was always less than 50% (Table 3) , this meant that the dimer was essentially present in two stereoconfigurations: donor (LL-DAP)-acceptor (meso-DAP) and donor (meso-DAP)-acceptor (meso-DAP). The two other possible configurations would be in very low amounts.
Mutation in the dapF gene of E. coli K-12 HfrH. The low extent of cross-linkage observed in the peptidoglycan of JC7623 dapF cells grown in Penassay medium prompted us to examine their morphology by optical microscopy. They appeared as short filaments of various length, but this was also the case in the parental cell population. Such a phenotype might be the consequence of previous mutagenizing treatments. Therefore, the dapF:Mu dlI PR13 mutation was introduced by P1 transduction in the chromosomal dapF gene of strain K-12 HfrH, which has a normal cell morphology. The resulting mutant showed no major morphological alterations when observed by optical microscopy. Strain HfrH dapF was grown in minimum medium and Penassay medium. As with strain JC7623 dapF, a high LL-DAP/meso-DAP ratio for the pool of free DAP was encountered (data not shown). Moreover, LL-DAP was also present in its peptidoglycan (Table 5) ; as with strain JC7623 dapF, the LL-DAP/meso-DAP ratio was higher in the peptidoglycan from cells grown in Penassay medium than in cells grown in minimum medium. Two additional observations were made with this strain. When considering early or midexponential as well as stationary-phase cells grown in Penassay medium, the peptidoglycan LL-DAP/meso-DAP ratio decreased as growth proceeded (Table 5) . Furthermore, in cells grown in minimum medium the value of this ratio doubled when L-lysine was added to the medium ( Table  5) .
Excretion of LL-DAP and N-succinyl-LL-DAP. Another effect of the high LL-DAP pool level in the HfrH dapF mutant was the accumulation of large amounts of LL-DAP in the growth medium, at least in the case of cells growing in minimum medium where it was readily detected. After growth of both parental and dapF strains in minimum medium, the cell-free culture media recovered were acidified to pH 2 with concentrated hydrochloric acid, and samples were analyzed with the amino acid analyzer. With the dapF mutant the amount of LL-DAP excreted was ca. 57 ,umol liter-' for a midexponential-phase culture (2 x 108 cells ml-') and 359 ixmol liter-' for an overnight stationary-phase culture. No LL-DAP was detected in the growth medium of the parental strain. It should be pointed out that LL-DAP excreted by the dapF mutant was free from meso-DAP. The release of LL-DAP in the growth medium was reminiscent of that of both meso-and LL-DAP observed with E. coli decarboxylase-deficient strains (7, 18) .
Amino acid analysis of the growth medium of the dapF mutant, performed without hydrolysis, revealed that another compound was excreted simultaneously with LL-DAP. After recovery and hydrolysis it was found to contain LL-DAP. Under the conditions followed for running the amino acid analyzer, it was eluted between aspartic acid and threonine at the same position as an authentic sample of N-succinyl- LL-DAP. Its identification with this compound was further substantiated by the same retention time on HPLC after dabsylation (Fig. 1) . The amount excreted was ca. 77 ,umol liter-' for a midexponential-phase culture and 600 ,umol liter-1 for an overnight stationary-phase culture. This compound accumulated also to some extent in the growth media of the parental strain but at one-third of the level observed with the dapF strain. N-Succinyl-LL-DAP was initially discovered as an intermediate in the biosynthesis of DAP by its accumulation in E. coli decarboxylase-deficient and succinyl-diaminopimelate desuccinylase-deficient strains (12, 13) . DISCUSSION The results reported in the present paper showed that LL-DAP was incorporated concomitantly with meso-DAP into the peptidoglycan of E. coli dapF strains. This further confirmed the fact that in such strains meso-DAP was formed, although the functional dapF gene was absent. Among different possibilities, we favored the hypothesis that LL-DAP was converted to meso-DAP by some other amino acid racemase acting nonspecifically and with a low efficiency (27) . The formation of meso-DAP in the dapF mutant thus appeared as a limiting step which was important in fixing the LL-and meso-DAP pools characterized by the high LL-DAP/meso-DAP ratios observed. The incorporation of LL-DAP into peptidoglycan was thus a consequence of this high ratio, which enabled LL-DAP to compete efficiently with the meso isomer as a substrate for the DAP-adding enzyme, although the Km value for it was 3,300-fold higher than that for the meso isomer.
The important variations of the LL-DAP/meso-DAP ratio of peptidoglycan observed with growth conditions undoubtly reflected variations of the free LL-and meso-DAP pools. However, correlations did not appear straightforward. For instance, with JC7623 dapF cells grown in Penassay medium it seemed somewhat paradoxical to have a high peptidoglycan LL-DAP/meso-DAP ratio and a not very high LL-DAP pool, which was presumably due to the repression of the DAP pathway by L-lysine originating from the medium (25) . A possible explanation for this high incorporation of LL-DAP into peptidoglycan is that owing to the lower LL.-DAP pool the conversion of LL-DAP to meso-DAP by the hypothetical unspecific racemase would not be very efficient, leading to a very low meso-DAP pool and thus to a still higher LL-DAP/meso-DAP pool ratio. The greatly increased incorporation of LL-DAP into the peptidoglycan of dapF cells grown in minimum medium supplemented with L-lysine substantiated this point of view.
Another factor that should be considered is the rate of peptidoglycan synthesis. The metabolism of the D-Ala-DAP cross-bridges is a complex interplay of many reactions (4, 5, 9, 17) . They are formed by a transpeptidation reaction involving pentapeptide monomers of the newly polymerized peptidoglycan functioning as donor units and other monomers functioning as acceptor units (17, 28) . Since only very low levels of pentapeptide monomer and tetrapentapeptide dimer were detectable in peptidoglycan, the pentapeptide subunits not used as donors and those used as acceptors are cleaved to tetrapeptide subunits (9) . This holds as well for both the LLand meso-DAP monomers of the dapF mutant (Fig. 4) . Furthermore, it has also been shown that during normal growth of E. coli the cross-linkages are cleaved, and the tetrapeptide monomers released can be used as acceptor units in the transpeptidation reaction (5, 17) . In the dapF mutant, the LL-DAP tetrapeptide monomer could thus originate from an LL-DAP donor unit or from an LL-DAP pentapeptide monomer and thus could be an end product no longer usable either as a donor or an acceptor. The meso-DAP tetrapeptide monomer was formed in the same way but could still be used as an acceptor in the formation of new dimers. Its availability was probably a critical factor for the formation of dimers. This was substantiated by the fact that, when comparing peptidoglycans from M63 and rich mediagrown cells, a correlation between the proportion of meso-DAP monomers present and the extent of cross-linkage was observed (Tables 3 and 4) . Moreover, there is probably little discrimination between LL-and meso-DAP pentapeptide monomers in their initial function as dimer donors, since the LL-DAP/meso-DAP ratio in the donor (44 and 65% for LBand Penassay medium-grown cells, respectively) reflected more or less that of the entire peptidoglycan (54 and 63%).
Considering that both LL-and meso-DAP are metabolic intermediates present in approximately equal amounts in cells with a normal dapF gene product (21) , one can wondel why evolution has led to the preferential use of meso-DAP in peptidoglycan. It could be that the D-D configuration of the cross-linkages is in some way essential for the three-dimensional structure of peptidoglycan. However, other bacterial peptidoglycans contain LL-DAP (8, 19, 29) , in some cases exclusively this isomer, but their peptide cross-bridges differ from that of E. coli. A more simple explanation could be that peptide cross-linkages with an L-L or D-L configuration are highly sensitive to essential endogenous periplasmic peptidases and therefore incompatible with peptidoglycan integrity.
The extent of cross-linkage observed with the dapF mutant grown in Penassay medium was apparently among the lowest yet described for a bacterial peptidoglycan (28) , perhaps the lowest still compatible in E. coli with peptidoglycan integrity, maintenance of cell shape, and cell viability. This result also stressed the great adaptability of peptidoglycan to various metabolic conditions, as recently exemplified by variations in amounts (22) and structure (26) . However, we caution that cross-linkage values were calculated simply from the ratios of the main monomer and dimer determined after their HPLC separation from the digestion products of crude sacculi. Although digestions were fairly complete, this approach may not necessarily reflect the exact state of cross-linkage of peptidoglycan. Future work should imply a quantitative analysis of the degradation products from purified peptidoglycan material.
